Format

Send to

Choose Destination
J Am Soc Nephrol. 2016 Oct;27(10):3079-3092. Epub 2016 Mar 3.

Proteomics of Urinary Vesicles Links Plakins and Complement to Polycystic Kidney Disease.

Author information

1
Department of Internal Medicine, Division of Nephrology & Transplantation, and.
2
Proteomics Center, Erasmus Medical Center, Rotterdam, The Netherlands.
3
Departments of Human Genetics.
4
Clinical Genetics, and.
5
Nephrology, Leiden University Medical Center, Leiden, The Netherlands; and.
6
Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.
7
Department of Internal Medicine, Division of Nephrology & Transplantation, and e.j.hoorn@erasmusmc.nl.

Abstract

Novel therapies in autosomal dominant polycystic kidney disease (ADPKD) signal the need for markers of disease progression or response to therapy. This study aimed to identify disease-associated proteins in urinary extracellular vesicles (uEVs), which include exosomes, in patients with ADPKD. We performed quantitative proteomics on uEVs from healthy controls and patients with ADPKD using a labeled approach and then used a label-free approach with uEVs of different subjects (healthy controls versus patients with ADPKD versus patients with non-ADPKD CKD). In both experiments, 30 proteins were consistently more abundant (by two-fold or greater) in ADPKD-uEVs than in healthy- and CKD-uEVs. Of these proteins, we selected periplakin, envoplakin, villin-1, and complement C3 and C9 for confirmation because they were also significantly overrepresented in pathway analysis and were previously implicated in ADPKD pathogenesis. Immunoblotting confirmed higher abundances of the selected proteins in uEVs from three independent groups of patients with ADPKD. Whereas uEVs of young patients with ADPKD and preserved kidney function already had higher levels of complement, only uEVs of patients with advanced stages of ADPKD had increased levels of villin-1, periplakin, and envoplakin. Furthermore, all five proteins correlated positively with total kidney volume. Analysis in kidney tissue from mice with kidney-specific, tamoxifen-inducible Pkd1 deletion demonstrated higher expression in more severe stages of the disease and correlation with kidney weight for each protein of interest. In summary, proteomic analysis of uEVs identified plakins and complement as disease-associated proteins in ADPKD. These proteins are new candidates for evaluation as biomarkers or targets for therapy in ADPKD.

KEYWORDS:

ADPKD; complement; cytoskeleton; genetic renal disease

PMID:
26940098
PMCID:
PMC5042669
DOI:
10.1681/ASN.2015090994
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center